Andrew Mears
Directeur Général chez DELTEX MEDICAL GROUP PLC
Fortune : 18 304 $ au 30/04/2024
Postes actifs de Andrew Mears
Sociétés | Poste | Début | Fin |
---|---|---|---|
DELTEX MEDICAL GROUP PLC | Directeur/Membre du Conseil | - | - |
Directeur Général | 13/06/2018 | - | |
Corporate Officer/Principal | 01/01/2016 | 13/06/2018 | |
Sales & Marketing | 01/01/1989 | 01/01/2016 | |
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Directeur/Membre du Conseil | 01/11/2004 | - |
Directeur Général | - | - | |
All-Party Parliamentary Groups | Corporate Officer/Principal | - | - |
Historique de carrière de Andrew Mears
Statistiques
Internationale
Royaume-Uni | 4 |
Opérationnelle
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
All-Party Parliamentary Groups |
- Bourse
- Insiders
- Andrew Mears
- Expérience